A multicentre study to determine the in vitro efficacy of flomoxef against extended-spectrum beta-lactamase producing Escherichia coli in Malaysia

A multicentre study to determine the in vitro efficacy of flomoxef against extended-spectrum beta-lactamase producing Escherichia coli in Malaysia

Show other versions (1)

Background The high burden of extended-spectrum beta-lactamase-producing (ESBL)-producing Enterobacterales worldwide, especially in the densely populated South East Asia poses a significant threat to the global transmission of antibiotic resistance. Molecular surveillance of ESBL-producing pathogens...

Full description

Bibliographic Details
Main Authors: Polly Soo Xi Yap, Chun Wie Chong, Sasheela Ponnampalavanar, Ramliza Ramli, Azian Harun, Tengku Zetty Maztura Tengku Jamaluddin, Anis Ahmed Khan, Soo Tein Ngoi, Yee Qing Lee, Min Yi Lau, Shiang Chiet Tan, Zhi Xian Kong, Jia Jie Woon, Siew Thong Mak, Kartini Abdul Jabar, Rina Karunakaran, Zalina Ismail, Sharifah Azura Salleh, Siti Suraiya Md Noor, Siti Norbaya Masri, Niazlin Mohd Taib, Azmiza Syawani Jasni, Loong Hua Tee, Kin Chong Leong, Victor Kok Eow Lim, Sazaly Abu Bakar, Cindy Shuan Ju Teh
Format: Article
Language:English
Published: PeerJ Inc. 2023-11-01
Series:PeerJ
Subjects:
Extended-spectrum beta-lactamase (ESBL)
Escherichia coli
Antimicrobial resistance
Flomoxef
Enterobacterales
Surgical site infection
Online Access:https://peerj.com/articles/16393.pdf

Similar Items

Similar Items